|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| The progestin-only pills and the levonorgestrel-releasing IUD: two |
| progestin-only contraceptives. |
| CLINICAL OBSTETRICS AND GYNECOLOGY. 1995 Dec;38(4):872-89. |
| The author reviewed available study findings in the literature to evaluate the merits, disadvantages, and unsettled |
| issues of progestin-only contraceptive pills (POPs) and the newly developed levonorgestrel-releasing (LNG) IUD. The |
| mechanism of POP action and the brands marketed are first considered, followed by discussion of safety |
| considerations, efficacy and compliance, side effects, clinical acceptability, continuation patterns, the advantages |
| of using POPs, current use, and issues to be addressed. The author then discusses the LNG IUD in sections on its |
| mode of action, studies used for evaluation, safety considerations, clinical performance, noncontraceptive effects, |
| and use perspectives and issues to be addressed. The benefits of POPs outweigh their risks, especially for |
| lactating and/or postpartum women, with available information suggesting that POPs are at least as safe as, if not |
| safer than, combined oral contraceptives (COCs). The incidence of nonmenstrual systemic side effects in POP |
| users, such as headaches, nausea, vomiting, and dizziness, tend to be milder, and their incidence may have been |
| overreported in previous studies. However, for POPs to be as effective as COCs, strict compliance is required. |
| Moreover, compared to COCs, POPs are more likely to cause menstrual disturbances in the first few months of use. |
| (PubHealth.info Document ID: CONT2T 3024-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "The progestin-only pills and the levonorgestrel-releasing |
| IUD: two progestin-only contraceptives.", is(are) Chi IC. The source of this article is "CLINICAL OBSTETRICS AND |
| GYNECOLOGY. 1995 Dec;38(4):872-89.". This article was published in 1995 in English language(s). |
| (PubHealth.info® Document ID: CONT2T 3024-06. All rights reserved with PubHealth.info) PIN: 8024 |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |